Tony Butler
Stock Analyst at Rodman & Renshaw
(0.75)
# 4,022
Out of 5,090 analysts
96
Total ratings
32.26%
Success rate
-13.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $14.33 | +74.46% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.94 | +467.01% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.22 | +1,375.41% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.04 | +635.40% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.53 | +2,944.14% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.08 | +825.93% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $56.88 | +31.86% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $96.14 | -63.59% | 7 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.61 | +9,745.75% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.51 | +760.93% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.07 | +607.21% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.43 | +948.95% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.82 | +2,934.72% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $4.22 | +255.45% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.45 | +55.04% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $4.37 | +289.02% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.93 | +4,123.92% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $10.61 | +465.50% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.79 | +13,307.82% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.30 | +1,902.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $1.98 | +18,081.82% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.46 | -63.37% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.87 | +702.14% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.32 | +657.58% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.53 | +171.25% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $9.61 | +1,044.64% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $12.34 | +7,682.73% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $14.33
Upside: +74.46%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.94
Upside: +467.01%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.22
Upside: +1,375.41%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.04
Upside: +635.40%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.53
Upside: +2,944.14%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.08
Upside: +825.93%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $56.88
Upside: +31.86%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $96.14
Upside: -63.59%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.61
Upside: +9,745.75%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.51
Upside: +760.93%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.07
Upside: +607.21%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.43
Upside: +948.95%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.82
Upside: +2,934.72%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $4.22
Upside: +255.45%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $6.45
Upside: +55.04%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $4.37
Upside: +289.02%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.93
Upside: +4,123.92%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $10.61
Upside: +465.50%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.79
Upside: +13,307.82%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.30
Upside: +1,902.00%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $1.98
Upside: +18,081.82%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.46
Upside: -63.37%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $1.87
Upside: +702.14%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.32
Upside: +657.58%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.53
Upside: +171.25%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $9.61
Upside: +1,044.64%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $12.34
Upside: +7,682.73%